Finoriq research workspace
BAXTER INTERNATIONAL INC (BAX) SEC Filings & Filing Highlights
Baxter International Inc. provides a portfolio of healthcare products in the United States. Review BAX SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
- Company
- BAXTER INTERNATIONAL INC (BAX)
- Ticker
- BAX
- Market Cap
- $11.5B
- Latest Price
- $22.22
- Industry
- Medical Devices
BAXTER INTERNATIONAL INC (BAX) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for BAXTER INTERNATIONAL INC (BAX).
| Event | Form | Date |
|---|---|---|
| The nine nominees for director were elected as followsOn May 5, 2026, the Company held its 2026 Annual Meeting. Of the 516,252,514 shares outstanding and entitled to vote, 483,423,846 shares we... | 8-K5.07 | 2026-05-08 |
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearAmendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K5.03 | 2026-05-08 |
| Executive Severance and Change in Control Plan and Hider Offer Letter Amendment On May 4, 2026,...Executive Severance and Change in Control Plan and Hider Offer Letter Amendment On May 4, 2026, the Compensation and Human Capital Committe... | 8-K5.02 | 2026-05-08 |
| BAXTER REPORTS FIRST-QUARTER 2026 RESULTSBAXTER REPORTS FIRST-QUARTER 2026 RESULTS | 8-K8.01 | 2026-04-30 |
| BAXTER REPORTS FIRST-QUARTER 2026 RESULTSBAXTER REPORTS FIRST-QUARTER 2026 RESULTS | 8-K2.02 | 2026-04-30 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.